Origins of Portal Hypertension in Nonalcoholic Fatty Liver Disease

Short article

(2017) Ana C. de Oliveira   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Optimizing EUS-guided liver biopsy sampling: comprehensive assessment of needle types and tissue acquisition techniques

(2017) Allison R. Schulman et al.   GASTROINTESTINAL ENDOSCOPY

Ultrasonography for Noninvasive Assessment of Portal Hypertension

(2017) Hitoshi Maruyama et al.   Gut and Liver

Performance characteristics of vibration-controlled transient elastography for evaluation of nonalcoholic fatty liver disease

(2017) Raj Vuppalanchi et al.   HEPATOLOGY

Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis

(2017) Parambir S. Dulai et al.   HEPATOLOGY

The anticoagulant rivaroxaban lowers portal hypertension in cirrhotic rats mainly by deactivating hepatic stellate cells

(2017) Marina Vilaseca et al.   HEPATOLOGY

Invasive and non-invasive assessment of portal hypertension

(2017) Jonathan Chung-Fai Leung et al.   Hepatology International

Gut–liver axis, cirrhosis and portal hypertension: the chicken and the egg

(2017) Juan P. Arab et al.   Hepatology International

Targeting the gut-liver axis in liver disease

(2017) Reiner Wiest et al.   JOURNAL OF HEPATOLOGY

Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD

(2017) Hannes Hagström et al.   JOURNAL OF HEPATOLOGY

Liver sinusoidal endothelial cells: Physiology and role in liver diseases

(2017) Johanne Poisson et al.   JOURNAL OF HEPATOLOGY

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

(2017) Philipp Schwabl et al.   JOURNAL OF HEPATOLOGY

Mitochondria-targeted antioxidant mitoquinone deactivates human and rat hepatic stellate cells and reduces portal hypertension in cirrhotic rats

(2017) Marina Vilaseca et al.   LIVER INTERNATIONAL

Multiparametric magnetic resonance imaging for the assessment of non-alcoholic fatty liver disease severity

(2017) Michael Pavlides et al.   LIVER INTERNATIONAL

The use of statins alone, or in combination with pioglitazone and other drugs, for the treatment of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis and related cardiovascular risk. An Expert Panel Statement

(2017) Vasilios G. Athyros et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis

(2017) Le Wang et al.   PLoS One

Correlation of transient elastography with hepatic venous pressure gradient in patients with cirrhotic portal hypertension: A study of 326 patients from India

(2017) Ashish Kumar et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Elastography methods for the non-invasive assessment of portal hypertension

(2017) Davide Roccarina et al.   Expert Review of Gastroenterology & Hepatology

Magnetic Resonance Elastography Shear Wave Velocity Correlates with Liver Fibrosis and Hepatic Venous Pressure Gradient in Adults with Advanced Liver Disease

(2017) Ahmed M. Gharib et al.   Biomed Research International

Novel treatment options for portal hypertension

(2017) Philipp Schwabl et al.   Gastroenterology Report

Magnetic Resonance Elastography for the Evaluation of Liver Fibrosis in Chronic Hepatitis B and C by Using Both Gradient-Recalled Echo and Spin-Echo Echo Planar Imaging: A Prospective Study

(2016) Yu Shi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Novel 3D Magnetic Resonance Elastography for the Noninvasive Diagnosis of Advanced Fibrosis in NAFLD: A Prospective Study

(2016) Rohit Loomba et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Nonalcoholic Fatty Liver Disease and the Gut Microbiome

(2016) Jerome Boursier et al.   Clinics in Liver Disease

Farnesoid X Receptor Agonists and Other Bile Acid Signaling Strategies for Treatment of Liver Disease

(2016) Emina Halilbasic et al.   DIGESTIVE DISEASES

New Developments on the Treatment of Liver Fibrosis

(2016) Yukinori Koyama et al.   DIGESTIVE DISEASES

Natural History of Nonalcoholic Fatty Liver Disease

(2016) George Boon-Bee Goh et al.   DIGESTIVE DISEASES AND SCIENCES

Emerging therapies for portal hypertension in cirrhosis

(2016) Harikumar Nair et al.   EXPERT OPINION ON EMERGING DRUGS

Addition of Simvastatin to Standard Therapy for the Prevention of Variceal Rebleeding Does Not Reduce Rebleeding but Increases Survival in Patients With Cirrhosis

(2016) Juan G. Abraldes et al.   GASTROENTEROLOGY

EUS-guided portal pressure measurement using a digital pressure wire with real-time remote display: a novel, minimally invasive technique for direct measurement in an animal model

(2016) Allison R. Schulman et al.   GASTROINTESTINAL ENDOSCOPY

EUS-guided portal pressure gradient measurement with a novel 25-gauge needle device versus standard transjugular approach: a comparison animal study

(2016) Jason Y. Huang et al.   GASTROINTESTINAL ENDOSCOPY

Microbiota-induced obesity requires farnesoid X receptor

(2016) Ava Parséus et al.   GUT

Liver stiffness in nonalcoholic fatty liver disease: A comparison of supersonic shear imaging, FibroScan, and ARFI with liver biopsy

(2016) Christophe Cassinotto et al.   HEPATOLOGY

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients

(2016) Jonathan Chung-Fai Leung et al.   HEPATOLOGY

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging

(2016) Naaventhan Palaniyappan et al.   JOURNAL OF HEPATOLOGY

Cerium oxide nanoparticles reduce steatosis, portal hypertension and display anti-inflammatory properties in rats with liver fibrosis

(2016) Denise Oró et al.   JOURNAL OF HEPATOLOGY

Sinusoidal communication in liver fibrosis and regeneration

(2016) Giusi Marrone et al.   JOURNAL OF HEPATOLOGY

Prediction of esophageal varices and variceal hemorrhage in patients with acute upper gastrointestinal bleeding

(2016) Don C Rockey et al.   JOURNAL OF INVESTIGATIVE MEDICINE

Osteopontin: A non-invasive parameter of portal hypertension and prognostic marker of cirrhosis

(2016) Radan Bruha et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Does pressure cause liver cirrhosis? The sinusoidal pressure hypothesis

(2016) Sebastian Mueller   WORLD JOURNAL OF GASTROENTEROLOGY

The FXR Agonist Obeticholic Acid Prevents Gut Barrier Dysfunction and Bacterial Translocation in Cholestatic Rats

(2015) Len Verbeke et al.   AMERICAN JOURNAL OF PATHOLOGY

Metformin reduces hepatic resistance and portal pressure in cirrhotic rats

(2015) Dinesh M. Tripathi et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Janus-kinase-2 relates directly to portal hypertension and to complications in rodent and human cirrhosis

(2015) Sabine Klein et al.   GUT

The prognostic value of hepatic venous pressure gradient in patients with cirrhosis is highly dependent on the accuracy of the technique

(2015) Gilberto Silva-Junior et al.   HEPATOLOGY

Development of hyperdynamic circulation and response to β-blockers in compensated cirrhosis with portal hypertension

(2015) Càndid Villanueva et al.   HEPATOLOGY

Hepatic dimethylarginine-dimethylaminohydrolase1 is reduced in cirrhosis and is a target for therapy in portal hypertension

(2015) Rajeshwar P. Mookerjee et al.   JOURNAL OF HEPATOLOGY

Expanding consensus in portal hypertension

(2015) Roberto de Franchis   JOURNAL OF HEPATOLOGY

Pivotal role of liver sinusoidal endothelial cells in NAFLD/NASH progression

(2015) Masashi Miyao et al.   LABORATORY INVESTIGATION

Probe-based confocal laser endomicroscopy quantitative morphometric markers associated with portal hypertension in duodenal mucosa

(2015) Eladio Rodriguez-Diaz et al.   LIVER INTERNATIONAL

Nonalcoholic Fatty Liver Disease: Portal Hypertension Due to Outflow Block in Patients without Cirrhosis

(2015) Masashi Hirooka et al.   RADIOLOGY

Assessment of Hepatic Vascular Network Connectivity with Automated Graph Analysis of Dynamic Contrast-enhanced US to Evaluate Portal Hypertension in Patients with Cirrhosis: A Pilot Study

(2015) Ivan Amat-Roldan et al.   RADIOLOGY

Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features

(2015) Luisa Vonghia et al.   PLoS One

Measurement of Portal Pressure

(2014) Juan G. Abraldes et al.   Clinics in Liver Disease

Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study

(2014) Rohit Loomba et al.   HEPATOLOGY

Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease

(2014) Changtao Jiang et al.   JOURNAL OF CLINICAL INVESTIGATION

Vascular pathobiology in chronic liver disease and cirrhosis – Current status and future directions

(2014) Yasuko Iwakiri et al.   JOURNAL OF HEPATOLOGY

Invasive and non-invasive diagnosis of cirrhosis and portal hypertension

(2014) Moon Young Kim   WORLD JOURNAL OF GASTROENTEROLOGY

Non-cirrhotic portal hypertension – Concept, diagnosis and clinical management

(2014) Edna Strauss et al.   Clinics and Research in Hepatology and Gastroenterology

Targeting the Gut–Liver Axis in Cirrhosis: Antibiotics and Non-Selective β-Blockers

(2013) Bjørn S. Madsen et al.   ADVANCES IN THERAPY

Spleen Stiffness in Patients With Cirrhosis in Predicting Esophageal Varices

(2013) Praveen Sharma et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Zonation of glucose and fatty acid metabolism in the liver: Mechanism and metabolic consequences

(2013) Brenda S. Hijmans et al.   BIOCHIMIE

Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats

(2013) Eugenio Rosado et al.   HEPATOLOGY

Role of vascular endothelial growth factor in the pathophysiology of nonalcoholic steatohepatitis in two rodent models

(2013) Stephanie Coulon et al.   HEPATOLOGY

Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats

(2013) Len Verbeke et al.   HEPATOLOGY

Relaxin modulates human and rat hepatic myofibroblast function and ameliorates portal hypertensionin vivo

(2013) Jonathan A. Fallowfield et al.   HEPATOLOGY

Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease

(2013) Rachel H. McMahan et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The global NAFLD epidemic

(2013) Rohit Loomba et al.   Nature Reviews Gastroenterology & Hepatology

Celecoxib Ameliorates Portal Hypertension of the Cirrhotic Rats through the Dual Inhibitory Effects on the Intrahepatic Fibrosis and Angiogenesis

(2013) Jin-Hang Gao et al.   PLoS One

Chronic Liver Disease: Noninvasive Subharmonic Aided Pressure Estimation of Hepatic Venous Pressure Gradient

(2013) John R. Eisenbrey et al.   RADIOLOGY

Lipid-Induced Toxicity Stimulates Hepatocytes to Release Angiogenic Microparticles That Require Vanin-1 for Uptake by Endothelial Cells

(2013) D. Povero et al.   Science Signaling

Non-alcoholic steatohepatitis: a microbiota-driven disease

(2013) Alexander R. Moschen et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Portal hypertension and liver cirrhosis in rats: effect of the β3-adrenoceptor agonist SR58611A

(2012) Valentina Vasina et al.   BRITISH JOURNAL OF PHARMACOLOGY

FXR ligands protect against hepatocellular inflammation via SOCS3 induction

(2012) Zhizhen Xu et al.   CELLULAR SIGNALLING

Prevalence and Indicators of Portal Hypertension in Patients With Nonalcoholic Fatty Liver Disease

(2012) Flavia D. Mendes et al.   Clinical Gastroenterology and Hepatology

Von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis

(2012) Monika Ferlitsch et al.   HEPATOLOGY

Adenoviral dominant-negative soluble PDGFRβ improves hepatic collagen, systemic hemodynamics, and portal pressure in fibrotic rats

(2012) V. Reichenbach et al.   JOURNAL OF HEPATOLOGY

PPARα activation improves endothelial dysfunction and reduces fibrosis and portal pressure in cirrhotic rats

(2012) Aina Rodríguez-Vilarrupla et al.   JOURNAL OF HEPATOLOGY

The transcription factor KLF2 mediates hepatic endothelial protection and paracrine endothelial–stellate cell deactivation induced by statins

(2012) Giusi Marrone et al.   JOURNAL OF HEPATOLOGY

Sinusoidal Endothelial Dysfunction Precedes Inflammation and Fibrosis in a Model of NAFLD

(2012) Marcos Pasarín et al.   PLoS One

Centrizonal Arteries and Microvessels in Nonalcoholic Steatohepatitis

(2011) Ryan M. Gill et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Intestinal decontamination inhibits TLR4 dependent fibronectin-mediated cross-talk between stellate cells and endothelial cells in liver fibrosis in mice

(2011) Qiang Zhu et al.   JOURNAL OF HEPATOLOGY

Increased production of sonic hedgehog by ballooned hepatocytes

(2011) Fatima Rangwala et al.   JOURNAL OF PATHOLOGY

Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease

(2010) C. BUREAU et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Hepatocellular ballooning in NASH

(2010) Stephen Caldwell et al.   JOURNAL OF HEPATOLOGY

Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats

(2010) Héctor García-Calderó et al.   JOURNAL OF HEPATOLOGY

Inhibition of Endothelin-1-Mediated Contraction of Hepatic Stellate Cells by FXR Ligand

(2010) Jiang Li et al.   PLoS One

Nonalcoholic fatty liver disease: A manifestation of the metabolic syndrome

(2009) C. H. KIM et al.   CLEVELAND CLINIC JOURNAL OF MEDICINE

Simvastatin Lowers Portal Pressure in Patients With Cirrhosis and Portal Hypertension: A Randomized Controlled Trial

(2009) Juan G. Abraldes et al.   GASTROENTEROLOGY

Role of β3-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis

(2009) Jonel Trebicka et al.   HEPATOLOGY

Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease

(2009) Vincent Wai-Sun Wong et al.   HEPATOLOGY

Kupffer cells in non-alcoholic fatty liver disease: The emerging view

(2009) György Baffy   JOURNAL OF HEPATOLOGY

Non-alcoholic steatohepatitis induces non-fibrosis-related portal hypertension associated with splanchnic vasodilation and signs of a hyperdynamic circulationin vitroandin vivoin a rat model

(2009) Sven Francque et al.   LIVER INTERNATIONAL

The Hepatic Microcirculation: Mechanistic Contributions and Therapeutic Targets in Liver Injury and Repair

(2009) Brigitte Vollmar et al.   PHYSIOLOGICAL REVIEWS

Portal Hypertension and Its Complications

(2008) Arun J. Sanyal et al.   GASTROENTEROLOGY

Differential pattern of lipid droplet-associated proteins andde novoperilipin expression in hepatocyte steatogenesis

(2008) Beate Katharina Straub et al.   HEPATOLOGY

Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis

(2008) Jacquelyn J. Maher et al.   HEPATOLOGY

Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response

(2008) Yan-Dong Wang et al.   HEPATOLOGY

Effects of diffuse fatty infiltration of the liver on portal vein flow hemodynamics

(2008) Ali Balci et al.   JOURNAL OF CLINICAL ULTRASOUND

Relationship of steatosis grade and zonal location to histological features of steatohepatitis in adult patients with non-alcoholic fatty liver disease

(2008) Naga Chalasani et al.   JOURNAL OF HEPATOLOGY

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

(2008) Scott L. Friedman   PHYSIOLOGICAL REVIEWS